Alpha1H demonstrated significant tumor reduction and immune activation in non-muscle invasive bladder cancer, with an 80% response rate and 59% average tumor shrinkage in high-dose groups. The drug ...
The bladder is a pouch-like muscular organ that holds urine from the kidneys until the fluid is eliminated from the body. When the bladder becomes full, nerves in the wall send a signal to the brain ...
New trials target hard-to-treat cancers with more personalized, less toxic therapies, including pediatric brain tumors, colorectal, ovarian, bladder cancers, and leukemia. FDA cleared Reyobiq for ...
OSLO, Norway, March 16, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two "trial in progress" presentations at the 2026 European Association of Urology congress ...
From a biomarker-driven strategy to delay or avoid cystectomy, to practice-changing perioperative immunotherapy, developments in bladder cancer frequently have made news over the past 12 months. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results